Hep B is the Holy Grail of gene therapy targets. A deal like this would be worth billions on paper in potential milestones and royalties. The upfront payment would be more than the current value of the company! Bring it on!
BLT Price at posting:
12.5¢ Sentiment: Buy Disclosure: Held
